ASTRAL Score for Ischaemic Stroke Outcome Prediction
ASTRAL (Acute STroke Registry and Analysis of Lausanne) score predicts unfavourable functional outcome (modified Rankin Scale 3-6) at 3 months after ischaemic stroke. Based on 6 variables assessed at admission. Score 0-50; higher score = worse outcome. AUC 0.85 for predicting poor outcome. Validated by Ntaios et al. 2012 in 1,645 patients. Useful for early prognostication and goals of care discussions.
Score interpretation
ASTRAL below 25 -- more favourable stroke outcome predicted
→ Optimistic but not certain prognosis; pursue active stroke management (thrombolysis/thrombectomy if eligible, stroke unit care); secondary prevention: antiplatelets (aspirin 300 mg then 75 mg OD or clopidogrel 75 mg OD), statin (atorvastatin 40-80 mg OD), antihypertensives; SWALLOW screen before oral intake; physiotherapy, occupational therapy, speech therapy assessment; early supported discharge if eligible; document ASTRAL score and prognosis discussion in notes; patient and family goals of care discussion.
ASTRAL 25-34 -- intermediate risk of poor 3-month outcome
→ Discuss prognosis with patient/family in sensitive and non-deterministic terms (score is probabilistic, not absolute); pursue all eligible acute treatments (thrombolysis, mechanical thrombectomy if LVO); stroke unit admission; SWALLOW screen; intensive multidisciplinary rehabilitation (physiotherapy, OT, SALT); dysphagia management; urinary continence support; early palliative care liaison if patient frail; DNACPR discussion if appropriate; 3-month mRS review as goal; secondary prevention medications; social work assessment for discharge planning.
ASTRAL 35 or above -- high probability of poor functional outcome at 3 months (above 80% chance mRS 3-6)
→ Frank but compassionate goals of care discussion with patient (if capacity) and family; not preclude active treatment -- thrombectomy/thrombolysis if eligible regardless of ASTRAL; ASTRAL helps frame discussions, not withhold treatment; if palliative approach: comfort-focused care, dysphagia management (speech therapy), PEG consideration only if agreed by patient/family and prognosis uncertain; DNACPR and ceiling of treatment; palliative care referral early; stroke specialist nurse support for family; nursing home placement planning; document all discussions and MDT decisions.
Interpretation bands for the ASTRAL Score. Apply clinical judgement and local guidance.
References
- Ntaios G et al. An integer-based score to predict functional outcome in acute ischemic stroke: the ASTRAL score. Neurology. 2012;78(24):1916-1922.
- NICE NG128. Stroke and transient ischaemic attack in over 16s: diagnosis and initial management. NICE. 2019 (updated 2023).
Related
Curated clinical cross-links plus same-class fallbacks.
- Aspirin (Loading Dose) · Antiplatelet — ACS / Ischaemic Stroke
- Alteplase (tPA) · Thrombolytic — Ischaemic Stroke / Massive PE
- Hydrocortisone (Oral Replacement) · Glucocorticoid Replacement
- Morphine (Oral) · Strong Opioid Analgesic — Step 3 WHO Ladder
- Oxycodone · Strong Opioid Analgesic — Step 3 WHO Ladder
- Donanemab (Anti-Amyloid Monoclonal Antibody) · Anti-Amyloid Immunotherapy (IgG1 — Targets Pyroglutamate-Modified Amyloid-β)
- Acute Stroke / TIA Assessment · NICE NG128; RCP Stroke Guidelines 2023
- Status Epilepticus (Adults) · NICE CG137; ESEM guidelines; RCP Neurology Guidelines
- Suspected Subarachnoid Haemorrhage · NICE NG228; RCEM 2023; AHA/ASA 2023
- Adult Head Injury · NICE NG232 (2023)
- Bell's Palsy / Facial Nerve Palsy · ENT UK 2017; AAN
- Vertigo Workup · ENT UK; NICE CKS
Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.